Abuse of antiparkinsonian drugs.
Abuse of the antiparkinsonian agents for their hallucinogenic and euphoriant effects is likely more prevalent than reported. Two clinical cases are presented, with discussion of symptoms and response to a diagnostic trial of physostigmine.
D000328:Adult; D000978:Antiparkinson Agents; D001590:Benztropine; D005260:Female; D006801:Humans; D008297:Male; D010830:Physostigmine; D011605:Psychoses, Substance-Induced / Q000175:diagnosis*; D019966:Substance-Related Disorders / Q000175:diagnosis*; D014282:Trihexyphenidyl
D000978:Antiparkinson Agents; D001590:Benztropine; D014282:Trihexyphenidyl; D010830:Physostigmine